Community Perspectives on Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndrome
2 Views
administrator
07/04/23
Join experts on treating higher-risk myelodysplastic syndromes and acute myeloid leukemia.
Supported by independent educational grants from AbbVie; Actinium Pharmaceuticals; Biomea Fusion; Gilead Sciences, Inc.; GlycoMimetics, Inc.; and Rigel Pharmaceuticals, Inc.
-
Category
Show more
Facebook Comments
No comments found